Blood-based Biomarkers for Alzheimer's Disease at the Primary Care Level.

Abroad (travel likely)Recruiting

Conditions

Alzheimer's Disease (AD)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

UZ Leuven/KU Leuven, Leuven, Belgium
Contact: Study coordinator (Serafien D'hooge, MD) · serafien.dhooge@kuleuven.be · +32 16 33 86 31

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Evaluate the Efficacy and Safety of TTYP01 Tablets in Early Symptomatic Alzheimer's Disease

AD · Early Alzheimer's Disease

Abroad (travel likely)RecruitingPHASE2

Chongqing, China

Moving Yourself in Space and Time: MYSTIC

Parkinson's Disease (PD) · Alzheimer's Disease (AD) and Related Disorders · Older Adults (60 - 85 Years Old)

Abroad (travel likely)Recruiting

Atlanta, United States

Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia

Mild Cognitive Impairment · Alzheimer's Disease · Alzheimer's Disease, Early Onset

Abroad (travel likely)Recruiting

Atlantis, United States · Aventura, United States

Social-cognitive Functioning: Validation of a New Neuropsychological Test

Alzheimer's Disease (AD) · Lewy Body Dementia (LBD) · Frontotemporal Degeneration (FTD)

Abroad (travel likely)Recruiting

Paris, France